Purinergic Signalling

SJR Rank #6,174H-index: 73SJR: 0.862Best quartile: Q2APC: US$4,690
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Molecular BiologyQ2
  • Cell BiologyQ3
  • Cellular and Molecular NeuroscienceQ3

Areas: Biochemistry, Genetics and Molecular Biology · Neuroscience

Most published research topics

Adenosine and Purinergic SignalingNeuroscience of respiration and sleepReceptor Mechanisms and SignalingVagus Nerve Stimulation ResearchNeurological Complications and SyndromesAdolescent and Pediatric HealthcareNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and EffectsNeuropeptides and Animal PhysiologyNeuroinflammation and Neurodegeneration Mechanisms

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

202220250306090120

Detailed Information

ISSN

1573-9538, 1573-9546

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.60

References per Document

63.23

Coverage

2004-2026

Scope

Nucleotides and nucleosides are primitive biological molecules that were utilized early in evolution both as intracellular energy sources and as extracellular signalling molecules. ATP was first identified as a neurotransmitter and later as a co-transmitter with all the established neurotransmitters in both peripheral and central nervous systems. Four subtypes of P1 (adenosine) receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of P2Y G protein-coupled receptors have currently been identified. Since P2 receptors were first cloned in the early 1990’s, there is clear evidence for the widespread distribution of both P1 and P2 receptor subtypes in neuronal and non-neuronal cells, including glial, immune, bone, muscle, endothelial, epithelial and endocrine cells.

Metrics from SCImago Journal Rank 2025. View on SCImago